Omnicell Reports Third Quarter Earnings

The Fort Worth-based company reports $11 million in profit for the third quarter of 2026.

Updated on Oct. 29, 2026 in Economic Indicators

Isometric editorial illustration of a modular pharmacy dispensing cabinet, representing the healthcare technology sector in a muted, clean style.
Fort Worth-based healthcare technology firm Omnicell reported $11 million in profit for the third quarter of 2026, with revenue totaling $307.9 million. AI Illustration. Upload story photo >

Live Poll

Do you generally trust corporate earnings reports that exceed Wall Street analyst expectations?

Omnicell posted third-quarter earnings of $11 million with total revenue reaching $307.9 million. The company reported a per-share profit of 24 cents, while adjusted earnings were 58 cents per share.

Why it matters

The latest results offer a snapshot of the companys financial standing as it navigates the latter half of the 2026 fiscal year. These figures allow investors and analysts to evaluate the firms performance against previous guidance and market expectations.

Omnicell posted revenue of $307.9 million during the period, compared to an average analyst estimate of 42 cents per share for earnings. The company now anticipates full-year revenue of $1.23 billion.

The players

Omnicell

Omnicell is a healthcare technology company based in Fort Worth that specializes in medication management solutions for health systems and pharmacies.

The details

The healthcare technology firm headquartered in Fort Worth provided updated projections for the remainder of the fiscal year. These estimates include fourth-quarter revenue guidance between $295 million and $301 million.

Timeline

  1. Omnicell reported $11 million in earnings for the third quarter of 2026.

  2. The fiscal fourth quarter is scheduled to end in December 2026.

Macro View

The report follows the transparency requirements set by the Sarbanes-Oxley Act of 2002 for public company disclosures. This release aligns with historical patterns of quarterly corporate reporting cycles within the broader technology sector.

These financial figures provide stakeholders with clarity regarding the companys operational health and future revenue targets. Investors may adjust their outlook based on the projected full-year earnings range of $2.48 to $2.56 per share.

The takeaway

Understanding a corporation's quarterly performance helps individuals gauge the stability of local employers and regional market health. Keep a close watch on companies that update their full-year guidance to align personal investment strategies with shifting corporate objectives.

Further reading

For a deeper analysis of regional performance trends, visit the Fort Worth Economic Indicators section.

Source note: This article includes information reported by WTOP.

Live Poll

Do you generally trust corporate earnings reports that exceed Wall Street analyst expectations?